Bioventix (LON:BVXP) Posts Quarterly Earnings Results

Bioventix (LON:BVXP) announced its quarterly earnings results on Monday. The biotechnology company reported GBX 72.27 ($0.93) EPS for the quarter, Digital Look Earnings reports. Bioventix had a return on equity of 69.09% and a net margin of 59.51%.

Bioventix Stock Performance

LON BVXP opened at GBX 2,405 ($31.07) on Tuesday. Bioventix has a one year low of GBX 2,400 ($31.01) and a one year high of GBX 4,800 ($62.02). The company has a market capitalization of £125.93 million, a price-to-earnings ratio of 15.55 and a beta of 0.35. The company’s 50-day simple moving average is GBX 2,894.46 and its two-hundred day simple moving average is GBX 3,357.13.

About Bioventix

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.